Latest filing published 17 Apr 2025 for Simcere Pharmaceutical Group Ltd..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tang Renhong appears in our data through filings on Simcere Pharmaceutical Group Ltd. shares, published by HKEX. The record holds 8 filings, for trades running from 12 November 2021 to 31 December 2024.
In open-market terms, that means 2 purchases worth €4.1M on one side and 4 sales on the other. The totals exclude 4 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at no purchases and 1 sale.
The record was last updated on 17 April 2025 with an open-market sale in Simcere Pharmaceutical Group Ltd. The last purchase on record was published on 15 November 2022, which is 1,439 days ago. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations